General Atlantic LLC Akero Therapeutics, Inc. Put Options Transaction History
General Atlantic LLC
- $2.96 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
269Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$382 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$364 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$306 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$288 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.82MShares$248 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.39B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...